Fadogia agrestis

No summary available for this substance.

Fadogia agrestis

Fadogia agrestis is a plant native to Nigeria and other parts of Africa, traditionally used for its aphrodisiac properties. Contemporary research suggests that it may also have potential benefits in improving testosterone levels and sexual behavior.

Category
Herbal Supplement
Molecular Formula
Not applicable for whole plant extracts
Mechanism of Action
The exact mechanism is not thoroughly understood, but it is believed to stimulate the hypothalamic-pituitary-gonadal axis, resulting in increased testosterone production.
Evidence Grade
C - Unclear or conflicting scientific evidence

Other Names

  • Bakin gagai
  • Black aphrodisiac
  • Yinusa

Primary Benefits

  • Enhances libido
  • Increases testosterone levels
  • Improves sexual behavior

Recommended Dosage

Typical Dose 450mg to 900mg
Frequency Once daily

Side Effects

  • Possible gastrointestinal upset
  • Potential for overstimulation

Precautions

  • Not recommended for use by pregnant or breastfeeding women
  • Should not be used by individuals with hormone-sensitive conditions

Interactions

  • May interact with hormone medications
  • Potential interaction with medications affecting liver enzymes

Key References

  • Yakubu, M. T., & Afolayan, A. J. (2009). Effect of aqueous extract of Bulbine natalensis (Baker) stem on the sexual behaviour of male rats. International journal of andrology, 32(6), 629-636.
  • Yakubu, M. T., Afolayan, A. J., & Sunmonu, T. O. (2010). Aphrodisiac potentials of the aqueous extract of Fadogia agrestis (Schweinf. Ex Hiern) stem in male albino rats. Asian Journal of Andrology, 12(6), 831-839.
Dr. Peter Attia: Exercise, Nutrition, Hormones for Vitality & Longevity
Optimizing Health and Longevity Through Nutrition, Hormones, and Exercise 1:47:50 0
“Just as a mention, and here I'm not making recommendations, but one supplement I've talked a lot about publicly is Fadogia agrestis, which is this weird Nigerian shrub that-”

No comments yet.

View all comments (0)